Belda, Marilou Z.

HRN: 21-85-52  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2023
CEFAZOLIN 1GM (VIAL)
05/08/2023
05/08/2023
IVT
2g
Prior To OR
For TAHBSO
Waiting Final Action 
05/08/2023
CEFAZOLIN 1GM (VIAL)
05/08/2023
05/09/2023
IV
2 Grams
Q 12hrs
S/P Tahbso Under Csea
Waiting Final Action 
05/09/2023
CEFUROXIME 500MG (TAB)
05/09/2023
05/16/2023
PO
500mg
BID
S/P TAHBSO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: